Charles River Laboratories
CRL
538 hedge funds and large institutions have $11.7B invested in Charles River Laboratories in 2020 Q4 according to their latest regulatory filings, with 87 funds opening new positions, 185 increasing their positions, 192 reducing their positions, and 33 closing their positions.
164% more first-time investments, than exits
New positions opened: 87 | Existing positions closed: 33
24% more call options, than puts
Call options by funds: $41M | Put options by funds: $33.2M
11% more capital invested
Capital invested by funds: $10.5B → $11.7B (+$1.16B)
9% more funds holding
Funds holding: 492 → 538 (+46)
0.01% more ownership
Funds ownership: 94.14% → 94.16% (+0.01%)
4% less repeat investments, than reductions
Existing positions increased: 185 | Existing positions reduced: 192
12% less funds holding in top 10
Funds holding in top 10: 17 → 15 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$92.5M |
| 2 |
MBI
Montrusco Bolton Investments
Montreal,
Quebec, Canada
|
+$56.5M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$52.2M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$46.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$46.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$117M |
| 2 |
Renaissance Technologies
New York
|
-$67.4M |
| 3 |
EIP
Epoch Investment Partners
New York
|
-$52.7M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$49.6M |
| 5 |
TSAM
Trinity Street Asset Management
London,
United Kingdom
|
-$44.9M |
CRL Hedge Fund Activity: Q4 2020 in Review
538 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2020, worth a combined $11.7B — up 11% from $10.5B a quarter earlier.
Buyers outnumbered sellers: 87 funds opened new CRL positions and 33 closed out — a net gain of 54 holders — while 185 added to existing stakes and 192 trimmed.
The largest buyer was Ameriprise, adding an estimated $92.5M. The largest seller was Wells Fargo, cutting an estimated $117M.
- 538 institutional investors held Charles River Laboratories (CRL) as of Q4 2020, up from 492 in Q3 2020.
- Funds reported $11.7B of Charles River Laboratories stock for Q4 2020, up 11% quarter-over-quarter.
- 87 funds opened new Charles River Laboratories positions in Q4 2020 and 33 closed out, a net change of +54 holders.
- The largest Charles River Laboratories buyer in Q4 2020 was Ameriprise, an estimated $92.5M added.
- The largest Charles River Laboratories seller in Q4 2020 was Wells Fargo, an estimated $117M sold.
Based on aggregated 13F filings for Q4 2020.